TD Cowen Forecasts Strong Price Appreciation for Addus HomeCare (NASDAQ:ADUS) Stock

Key Points

• TD Cowen raised its Addus HomeCare price target to $145 from $131 and reaffirmed a Buy rating, implying 15.3% upside from the share price cited in the report.
• Analyst views are mixed overall: MarketBeat’s consensus rating is Hold, with an average price target of $131.89; six analysts rate the stock Buy, four Hold, and one Sell.
• Addus beat quarterly earnings estimates, reporting EPS of $1.83 versus $1.79 expected, while revenue grew 7% year over year to $387.7 million but came in slightly below forecasts.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) had its target price hoisted by analysts at TD Cowen from $131.00 to $145.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm currently has a "buy" rating on the stock. TD Cowen's price objective would indicate a potential upside of 15.30% from the company's current price.

Other equities research analysts have also issued reports about the company. Raymond James Financial set a $137.00 price target on Addus HomeCare in a research note on Monday, September 28th. Citigroup downgraded shares of Addus HomeCare from a "market outperform" rating to a "neutral" rating in a report on Monday, September 14th. Barclays boosted their price objective on Addus HomeCare from $96.00 to $101.00 and gave the stock an "underweight" rating in a research note on Wednesday. Bank of America lowered Addus HomeCare from a "buy" rating to a "neutral" rating and dropped their price target for the company from $140.00 to $125.00 in a research report on Monday, September 14th. Finally, Truist Financial upped their price target on Addus HomeCare from $135.00 to $148.00 and gave the stock a "buy" rating in a research note on Thursday. Six research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $131.89.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS traded down $2.18 during trading on Thursday, hitting $125.76. 163,972 shares of the company were exchanged, compared to its average volume of 236,738. The firm's fifty day moving average price is $117.35 and its 200 day moving average price is $106.71. The company has a market cap of $2.35 billion, a price-to-earnings ratio of 21.01, a PEG ratio of 1.80 and a beta of 0.75. Addus HomeCare has a 1 year low of $87.95 and a 1 year high of $131.59. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.79 by $0.04. Addus HomeCare had a return on equity of 10.37% and a net margin of 7.39%. The company had revenue of $387.74 million for the quarter, compared to analyst estimates of $388.72 million. During the same quarter in the prior year, the company earned $1.56 earnings per share. Addus HomeCare's revenue was up 7.0% compared to the same quarter last year. On average, sell-side analysts expect that Addus HomeCare will post 6.33 earnings per share for the current fiscal year.

Institutional Trading of Addus HomeCare

Institutional investors and hedge funds have recently modified their holdings of the stock. Hsbc Holdings PLC lifted its stake in Addus HomeCare by 73.3% in the second quarter. Hsbc Holdings PLC now owns 24,463 shares of the company's stock valued at $2,446,000 after acquiring an additional 10,350 shares during the last quarter. Summit Creek Advisors LLC acquired a new stake in shares of Addus HomeCare during the 2nd quarter worth approximately $8,552,000. Bank of America Corp DE grew its position in Addus HomeCare by 11.3% in the first quarter. Bank of America Corp DE now owns 323,037 shares of the company's stock valued at $30,252,000 after acquiring an additional 32,714 shares during the last quarter. Globeflex Capital L P bought a new position in Addus HomeCare in the 2nd quarter valued at approximately $1,635,000. Finally, The Manufacturers Life Insurance Company bought a new stake in Addus HomeCare during the 2nd quarter worth approximately $901,000. 95.35% of the stock is owned by institutional investors.

Addus HomeCare News Roundup

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q3 earnings beat on profit. Addus reported adjusted EPS of $1.83, above the roughly $1.79 consensus and up from $1.56 a year earlier. Revenue rose 7% to $387.7 million, though it was slightly below analyst estimates. The profit growth is a positive signal, with the small revenue miss a qualification. Addus Q3 2026 earnings call highlights
• Positive Sentiment: AccentCare deal and margin outlook offer a growth catalyst. Addus outlined a Q1 2027 expected closing for its acquisition of AccentCare’s personal care division and expects full-year adjusted EBITDA margin in the 13% range. The acquisition could expand its personal-care platform, although execution and closing remain ahead. Addus outlines AccentCare close and margin outlook
• Neutral Sentiment: Medicaid policy is a possible but uncertain tailwind. Post-election discussion of Medicare for All has put home-care providers such as Addus in focus, given its Medicaid exposure and the proposals’ emphasis on home- and community-based care. Legislation is not imminent, and any benefit would depend on final reimbursement rules. Could the Midterms Revive Medicare for All?
• Neutral Sentiment: Caregiver scheduling remains an operational balancing act. Caregivers’ preference for 40-hour workweeks is shaping Addus’ personal-care census strategy. Better alignment could help staffing, but the effect on service capacity and growth is not yet clear. Caregiver desires for 40-hour weeks shape Addus strategy
• Negative Sentiment: Barclays maintained an underweight view. The firm raised its price target from $96 to $101 but still rated the shares “underweight,” signaling concern that the stock’s valuation leaves downside risk. Barclays stock recommendations

About Addus HomeCare

Addus HomeCare Inc NASDAQ: ADUS provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company's personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.